Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

Lancet Infectious Diseases
Nov 2021 Volume 21 Number 11 p1471-1612, e341-e362
https://www.thelancet.com/journals/laninf/issue/current

 

Articles
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Madhumita Shrotri, et al.
Open Access